Nothing Special   »   [go: up one dir, main page]

Johnson et al., 1991 - Google Patents

Stability of atriopeptin III in poly (D, L-lactide-co-glycolide) microspheres

Johnson et al., 1991

Document ID
15749009171434387969
Author
Johnson R
Lanaski L
Gupta V
Griffin M
Gaud H
Needham T
Zia H
Publication year
Publication venue
Journal of controlled release

External Links

Snippet

The stability ofatriopeptin III (APIII) encapsulated in poly (d, l-lactide-co-glycolide)(PLGA) microspheres has been investigated and compared to the stability of APIII alone. When the microspheres are shaken in Tris-buffered Ringer's (pH 7.4) at 40° C, the APIII inside of the …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/30—Macromolecular compounds
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin, zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48169—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being an organic macromolecular compound, i.e. an oligomeric, polymeric, dendrimeric molecule
    • A61K47/48176—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being an organic macromolecular compound, i.e. an oligomeric, polymeric, dendrimeric molecule the organic macromolecular compound has been obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly(meth)acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases; Films; Fibres of the matrix type containing drug

Similar Documents

Publication Publication Date Title
Johnson et al. Stability of atriopeptin III in poly (D, L-lactide-co-glycolide) microspheres
Maulding Prolonged delivery of peptides by microcapsules
US6306406B1 (en) Drug delivery system involving interaction between protein or polypeptide and hydrophobic biodegradable polymer
US6743446B2 (en) Methods for stabilizing biologically active agents encapsulated in biodegradable controlled-release polymers
Witschi et al. Influence of the microencapsulation method and peptide loading on poly (lactic acid) and poly (lactic-co-glycolic acid) degradation during in vitro testing
KR100293882B1 (en) Salt of Carboxy Terminal Polyester with Peptide
AU653771B2 (en) Stabilization of proteins by cationic biopolymers
Jameela et al. Progesterone-loaded chitosan microspheres: a long acting biodegradable controlled delivery system
CA2071840C (en) Method for producing protein microspheres
Park et al. Importance of in vitro experimental conditions on protein release kinetics, stability and polymer degradation in protein encapsulated poly (D, L-lactic acid-co-glycolic acid) microspheres
Cohen et al. Controlled delivery systems for proteins based on poly (lactic/glycolic acid) microspheres
Saltzman et al. Intracranial delivery of recombinant nerve growth factor: release kinetics and protein distribution for three delivery systems
EP0805678B1 (en) Surface-modified nanoparticles and method of making and using same
KR20010002589A (en) Process for preparing biodegradable microspheres containing physiologically active agents
Kostanski et al. A novel in vitro release technique for peptide-containing biodegradable microspheres
Uchida et al. Optimization of preparative conditions for polylactide (PLA) microspheres containing ovalbumin
Wang et al. Mechanistic evaluation of the glucose-induced reduction in initial burst release of octreotide acetate from poly (D, L-lactide-co-glycolide) microspheres
CN101646424A (en) Be used for the compositions of controlled-release of exendin and microsphere and preparation method thereof
Nam et al. Protein loaded biodegradable microspheres based on PLGA-protein bioconjugates
CZ300755B6 (en) LHRH antagonist complex, process for preparing immobilized peptide composition and medicament containing said complex
Miyajima et al. The effects of drug physico-chemical properties on release from copoly (lactic/glycolic acid) matrix
JPH05503504A (en) Porous microspheres for drug delivery and their manufacturing method
KR101688666B1 (en) Controlled-released peptide formulations
Soriano et al. Release control of albumin from polylactic acid microspheres
内田享弘 et al. Optimization of Preparative Conditions for Polylactide (PLA) Microspheres Containing Ovalbumin.